Department of Pediatric Orthopedic Surgery, Dana Dwek Children's Hospital, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
International Center for Limb Lengthening, Rubin Institute for Advanced Orthopedics, Sinai Hospital of Baltimore, Baltimore, MD, USA.
Clin Orthop Relat Res. 2024 Nov 1;482(11):2075-2085. doi: 10.1097/CORR.0000000000003119. Epub 2024 Jun 4.
Magnetic intramedullary lengthening nailing has demonstrated benefits over external fixation devices for femoral bone lengthening. These include avoiding uncomfortable external fixation and associated pin site infections, scarring, and inhibition of muscle or joint function. Despite this, little has changed in the field of biologically enhanced bone regeneration. Venting the femoral intramedullary canal at the osteotomy site before reaming creates egress for bone marrow during reaming. The reamings that are extruded from vent holes may function as a prepositioned bone graft at the distraction gap. The relationship between venting and the consolidation of regenerating bone remains unclear.
QUESTIONS/PURPOSES: (1) Do bone marrow reamings extruded through venting holes enhance the quality of bone regeneration and improve healing indices and consolidation times? (2) Is venting associated with a higher proportion of complications than nonventing?
We performed a retrospective study of femoral lengthening performed at one hospital from December 2012 to February 2022 using a magnetic intramedullary lengthening nail with or without venting at the osteotomy site before reaming. This was a generally sequential series, in which the study groups were assembled as follows: Venting was performed between July 2012 and August 2016 and again from November 2021 onward. Nonventing was used between October 2016 and October 2021 because the senior author opted to create drill holes after the reaming procedure to avoid commitment to the osteotomy level before completing the reaming procedure. Outcomes were evaluated based on bone healing time, time to achieve full weightbearing, and complications. Sixty-one femoral lengthening procedures were studied (in 33 male and 28 female patients); two patients were excluded because of implant breakage. The mean age was 17 ± 5 years. The mean amount of lengthening was 55 ± 13 mm in the venting group and 48 ± 16 mm in the nonventing group (mean difference 7 ± 21 [95% CI 2 to 12]; p = 0.07). The healing index was defined as the time (in days) required for three cortices to bridge with new bone formation divided by the length (in cm) lengthened during the clinical protocol. This index signifies the bone formation rate achieved under the specific conditions of the protocol. Full weightbearing was allowed upon bridging the regenerated gap on three sides. Consolidation time was defined as the total number of days from the completion of the lengthening phase until adequate bone union (all three cortices healed) was achieved and full weightbearing was permitted. This time frame represents the entire healing process after the lengthening is complete divided by the amount of lengthening achieved (in cm). Patient follow-up was conducted meticulously at our institution, and we adhered to a precise schedule, occurring every 2 weeks during the distraction phase and every 4 weeks during the consolidation phase. There were no instances of loss to follow-up. Every patient completed the treatment successfully, reaching the specified milestones of weightbearing and achieving three cortexes of bone bridging.
The mean healing index time in the venting group was faster than that in the nonventing group (21 ± 6 days/cm versus 31 ± 22 days/cm, mean difference 10 ± 23 [95% CI 4 to 16]; p = 0.02). The mean consolidation time was faster in the venting group than the nonventing group (10 ± 6 days/cm versus 20 ± 22 days/cm; mean difference 10 ± 23 [95% CI 4 to 15]; p = 0.02). No medical complications such as deep vein thrombosis or fat or pulmonary embolism were seen. Two patients had lengthy delays in regenerate union, both of whom were in the nonventing group (healing indexes were 74 and 62 days/cm; consolidation time was 52 and 40 days/cm).
Femoral lengthening with a magnetic intramedullary lengthening nail healed more quickly with prereaming venting than with nonventing, and it allowed earlier full weightbearing without any major associated complications. Future studies should evaluate whether there is a correlation between the number of venting holes and improvement in the healing index and consolidation time.
Level III, therapeutic study.
与外部固定装置相比,髓内磁性延长钉在股骨延长方面具有优势。这些优势包括避免了不舒适的外部固定和相关的针道感染、疤痕和肌肉或关节功能的抑制。尽管如此,在促进骨再生的生物学领域几乎没有变化。在扩孔前在截骨部位切开髓内管通气,为扩孔时骨髓的排出留出通道。从通气孔挤出的扩孔物可能在延长间隙中作为预先放置的骨移植物发挥作用。通气与再生骨的整合之间的关系尚不清楚。
问题/目的:(1) 通过通气孔挤出的骨髓扩孔物是否能提高骨再生质量,改善愈合指数和整合时间?(2) 通气与非通气相比,并发症的比例是否更高?
我们对一家医院 2012 年 12 月至 2022 年 2 月期间使用磁性髓内延长钉进行的股骨延长手术进行了回顾性研究,这些手术在扩孔前在截骨部位进行了通气或未通气。这是一个一般的连续系列,研究组是按照以下方式组建的:2012 年 7 月至 2016 年 8 月进行通气,2021 年 11 月以后再次进行通气。2016 年 10 月至 2021 年 10 月期间使用非通气,因为资深作者选择在扩孔后在扩孔部位钻洞,以避免在完成扩孔前对截骨部位做出承诺。根据骨愈合时间、达到完全负重的时间和并发症来评估结果。研究了 61 例股骨延长手术(33 例男性和 28 例女性患者);两名患者因植入物断裂而被排除。平均年龄为 17 ± 5 岁。通气组的平均延长长度为 55 ± 13mm,非通气组为 48 ± 16mm(平均差异 7 ± 21[95%CI 2 至 12];p=0.07)。愈合指数定义为新骨形成时需要 3 个皮质桥接的时间(以天为单位)除以临床方案中延长的长度(以厘米为单位)。这个指数表示在方案的特定条件下实现的骨形成率。当再生间隙的三面桥接时,允许完全负重。整合时间定义为从延长阶段完成到获得足够的骨愈合(所有三个皮质都愈合)并允许完全负重的总天数。这个时间框架代表了延长完成后整个愈合过程除以所实现的延长量(以厘米为单位)。我们机构对患者进行了细致的随访,并且严格按照规定的时间表进行,在延长阶段每 2 周进行一次,在整合阶段每 4 周进行一次。没有任何失访的情况。每个患者都成功地完成了治疗,达到了规定的负重和三个皮质桥接的里程碑。
通气组的平均愈合指数时间比非通气组快(21 ± 6 天/cm 比 31 ± 22 天/cm,平均差异 10 ± 23[95%CI 4 至 16];p=0.02)。通气组的平均整合时间比非通气组短(10 ± 6 天/cm 比 20 ± 22 天/cm;平均差异 10 ± 23[95%CI 4 至 15];p=0.02)。没有出现深静脉血栓形成或脂肪或肺栓塞等医疗并发症。两名患者的再生骨愈合延迟时间较长,均为非通气组(愈合指数分别为 74 天/cm 和 62 天/cm;整合时间分别为 52 天/cm 和 40 天/cm)。
与非通气相比,髓内磁性延长钉股骨延长在扩孔前进行预通气愈合更快,并且可以更早地完全负重,而不会出现任何主要的相关并发症。未来的研究应该评估通气孔的数量与愈合指数和整合时间改善之间是否存在相关性。
三级,治疗性研究。